APA (7th ed.) Citation

Pawlowski, T., Malyszczak, K., Pawlak, D., Inglot, M., Zalewska, M., Grzywacz, A., . . . Frydecka, D. (2023). HTR1A, TPH2, and 5-HTTLPR Polymorphisms and Their Impact on the Severity of Depressive Symptoms and on the Concentration of Tryptophan Catabolites during Hepatitis C Treatment with Pegylated Interferon-α2a and Oral Ribavirin (PEG-IFN-α2a/RBV). MDPI AG.

Chicago Style (17th ed.) Citation

Pawlowski, Tomasz, et al. HTR1A, TPH2, and 5-HTTLPR Polymorphisms and Their Impact on the Severity of Depressive Symptoms and on the Concentration of Tryptophan Catabolites During Hepatitis C Treatment with Pegylated Interferon-α2a and Oral Ribavirin (PEG-IFN-α2a/RBV). MDPI AG, 2023.

MLA (9th ed.) Citation

Pawlowski, Tomasz, et al. HTR1A, TPH2, and 5-HTTLPR Polymorphisms and Their Impact on the Severity of Depressive Symptoms and on the Concentration of Tryptophan Catabolites During Hepatitis C Treatment with Pegylated Interferon-α2a and Oral Ribavirin (PEG-IFN-α2a/RBV). MDPI AG, 2023.